Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling

Am J Physiol Cell Physiol. 2018 Apr 1;314(4):C389-C403. doi: 10.1152/ajpcell.00258.2017. Epub 2017 Dec 13.

Abstract

Platelet-derived growth factor receptor (PDGFR) signaling plays an important role in the fundamental biological activities of many cells that compose musculoskeletal tissues. However, little is known about the role of PDGFR signaling during tendon growth and remodeling in adult animals. Using the hindlimb synergist ablation model of tendon growth, our objectives were to determine the role of PDGFR signaling in the adaptation of tendons subjected to a mechanical growth stimulus, as well as to investigate the biological mechanisms behind this response. We demonstrate that both PDGFRs, PDGFRα and PDGFRβ, are expressed in tendon fibroblasts and that the inhibition of PDGFR signaling suppresses the normal growth of tendon tissue in response to mechanical growth cues due to defects in fibroblast proliferation and migration. We also identify membrane type-1 matrix metalloproteinase (MT1-MMP) as an essential proteinase for the migration of tendon fibroblasts through their extracellular matrix. Furthermore, we report that MT1-MMP translation is regulated by phosphoinositide 3-kinase/Akt signaling, while ERK1/2 controls posttranslational trafficking of MT1-MMP to the plasma membrane of tendon fibroblasts. Taken together, these findings demonstrate that PDGFR signaling is necessary for postnatal tendon growth and remodeling and that MT1-MMP is a critical mediator of tendon fibroblast migration and a potential target for the treatment of tendon injuries and diseases.

Keywords: extracellular matrix; fibroblast; matrix metalloproteinase; platelet-derived growth factor receptor; tenocyte.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Becaplermin / pharmacology
  • Benzimidazoles / pharmacology
  • Cell Movement
  • Cell Proliferation
  • Disease Models, Animal
  • Extracellular Matrix / enzymology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology*
  • Fibroblasts / pathology
  • Male
  • Matrix Metalloproteinase 14 / genetics
  • Matrix Metalloproteinase 14 / metabolism
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Phosphatidylinositol 3-Kinase / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism
  • Quinolines / pharmacology
  • Receptor, Platelet-Derived Growth Factor alpha / antagonists & inhibitors
  • Receptor, Platelet-Derived Growth Factor alpha / genetics
  • Receptor, Platelet-Derived Growth Factor alpha / metabolism*
  • Receptor, Platelet-Derived Growth Factor beta / antagonists & inhibitors
  • Receptor, Platelet-Derived Growth Factor beta / metabolism*
  • Signal Transduction* / drug effects
  • Tendon Injuries / enzymology*
  • Tendon Injuries / genetics
  • Tendon Injuries / pathology
  • Tendons / drug effects
  • Tendons / enzymology*
  • Tendons / growth & development*
  • Tendons / pathology

Substances

  • Benzimidazoles
  • CP-673,451
  • Mmp14 protein, mouse
  • Protein Kinase Inhibitors
  • Quinolines
  • Becaplermin
  • Phosphatidylinositol 3-Kinase
  • Receptor, Platelet-Derived Growth Factor alpha
  • Receptor, Platelet-Derived Growth Factor beta
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases
  • Matrix Metalloproteinase 14